Zai Lab Ltd at JPMorgan Healthcare Conference Transcript
Thanks, everyone. Welcome to Tuesday morning of the 41st Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Malcolm Kuno, and Priyanka Grover from the team. Our next presenting company is Zai Lab and presenting on behalf of the company, we have the CEO, Samantha Du. Samantha?
Thank you, Anupam. Good morning, everyone. It's such a great pleasure to be with you here today. Slide #2 is the safe harbor slide. I'll skip to just Slide #3, please. Zai Lab was founded 14 years ago with ambition to bring first or best-in-class assets to patients first in China, than around the world. Over the last [3] years, we have a -- really the team worked very hard and to seize this once in the [nutrition] opportunity as a biopharma leader in China through dedication, hard work, OS, like R&D, BD commercial team. So I'm here to want to thank my team for what you have
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |